News - Page 202 - Psychedelic Alpha

Our 🎯 Q1 2026 Psychedelic Pipeline Bullseye Charts are now available.

Read more about the article Cybin Announces API Synthesis and Optimization of Multiple Tryptamine Derivatives and Nomination of Two Deuterated Candidates for Full IND Enabling Studies Based on Second Milestone Achievement Pursuant to the Adelia Acquisition

Cybin Announces API Synthesis and Optimization of Multiple Tryptamine Derivatives and Nomination of Two Deuterated Candidates for Full IND Enabling Studies Based on Second Milestone Achievement Pursuant to the Adelia Acquisition

Post published:March 9, 2021
Post category:Press Release

Read more about the article Optimi Health Accelerates Psilocybin Clinical Trial Program with IMPACT

Optimi Health Accelerates Psilocybin Clinical Trial Program with IMPACT

Post published:March 9, 2021
Post category:Press Release

Read more about the article Red Light Holland’s Psychedelic Virtual Reality Experience, Wisdom, Narrated by Global Comedy Superstar Russell Peters, Accepted to Steam, the Largest Digital Distribution Platform for PC Gaming

Red Light Holland’s Psychedelic Virtual Reality Experience, Wisdom, Narrated by Global Comedy Superstar Russell Peters, Accepted to Steam, the Largest Digital Distribution Platform for PC Gaming

Post published:March 9, 2021
Post category:Press Release

Read more about the article PharmaDrug Announces Drug-Repurposing Expert Moshe Rogosnitzky Joins Sairiyo Therapeutics Scientific and Clinical Advisory Board

PharmaDrug Announces Drug-Repurposing Expert Moshe Rogosnitzky Joins Sairiyo Therapeutics Scientific and Clinical Advisory Board

Post published:March 9, 2021
Post category:Press Release

Numinus to expand state-of-the-art psychedelics research laboratory

Post published:March 9, 2021
Post category:Press Release

Read more about the article COMPASS Pathways plc announces financial results and business highlights for fourth quarter and year-end 2020

COMPASS Pathways plc announces financial results and business highlights for fourth quarter and year-end 2020

Post published:March 9, 2021
Post category:Press Release

Read more about the article Psychedelics Research Review: February 2021

Psychedelics Research Review: February 2021

Post published:March 9, 2021
Post category:Psychedelics Research Review

Read more about the article NeonMind Engages Pharma Executive Philippe Martin to Advance its Psilocybin Drug Candidates for Obesity

NeonMind Engages Pharma Executive Philippe Martin to Advance its Psilocybin Drug Candidates for Obesity

Post published:March 9, 2021
Post category:Press Release

Read more about the article MINDCURE Receives Unconditional Ethics Approval for its Psychedelic Integration Protocol Research Study

MINDCURE Receives Unconditional Ethics Approval for its Psychedelic Integration Protocol Research Study

Post published:March 9, 2021
Post category:Press Release

Better Plant Appoints Branding Expert Perry Chua as Chief Creative Officer

Post published:March 9, 2021
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond. Psy Alpha Ltd is a company registered in England and Wales (16989109).

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.